neihulizumab (ALTB-168) - AltruBio
Jakafi (ruxolitinib) - Novartis, Incyte
https://ash.confex.com/ash/2022/webprogram/Paper163027.html
 
Sameem Abedin, MD1, Mehdi Hamadani, MD1, Shernan G Holtan, MD2, Gary J. Schiller, MD3, Molly Gallogly, MD, PhD4, Edmund K. Waller, MD, PhD5, Satyajit Kosuri, MD6*, Sunil H Abhyankar, MD7, Sarah M. Anand, MD8*, Mahasweta Gooptu, MD9, Iming Cho, PhD10*, Simona Reed, PhD10*, Shih-Yao Lin, MD, PhD10*, Jesse W Hall, MD10* and Paul J Martin, MD11
 
Nov 4, 2022
 
Prev Next